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Abstract Biosynthetic adaptation of endophytic bacteria
to chemically support host plant is very remarkable. Hence
these organisms from medicinal plants are considered as
highly valuable sources for natural products with diverse
bioactivity. Their metabolite diversity and biosynthetic
versatility have been increasingly explored for drug dis-
covery. In this study, an endophytic Bacillus mojavensis
with broad spectrum antibacterial properties has been
analyzed for the chemical basis of its activity. By LC–MS/
MS the organism was identified to have the biosynthetic
ability to produce lipopeptides surfactin and fengycin. The
impressive antibacterial activity of B. mojavensis as
reported in the study indicates its broad antimicrobial
applications.
Keywords Endophytic Bacillus mojavensis  Bacopa
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Introduction
Endophytic bacteria and host plant mutualistically support
each other to manage various environmental stresses.
Biodiversity richness and biosynthetic versatility of endo-
phytes make them a treasure trove of unexplored natural
products (Jasim et al. 2013a). Microbial production of
diverse chemical scaffolds with broad phyto-interactive or
protective properties may expect to provide preference for
their endophytic life. Identification of such promising iso-
lates can have immense applications in various fields
ranging from clinical, industry to agriculture.
One of the most important bacterial groups with com-
mon endophytic association with plants and heavy depo-
sition of biosynthetic pathway include those of the Bacillus
sp. Various species of Bacillus have been reported to have
remarkable distribution of lipopeptide compounds synthe-
sized by non-ribosomal peptide synthase (NRPS) (Moyne
et al. 2004). These compounds have a common amphi-
pathic structure with a hydrophilic peptide and a
hydrophobic fatty acid region. The lipopeptide compounds
synthesized by Bacillus spp. are considered to have the
potential to manage infections caused by multidrug resis-
tant and biofilm forming pathogens (Fracchia et al. 2015;
Meena and Kanwar 2015). Rapid development of microbial
resistance against lipopeptides is prevented by
direct membrane binding based mechanism of action of
these compounds (Straus and Hancock 2006). Because of
these, exploration of novel sources for bacterial strains
with multipotent lipopeptide synthesizing property is very
important. This property has also been demonstrated in
relatively new members of genus Bacillus like B.
mojavensis. They differ from the related Bacillus subtilis
by fatty acid composition, DNA sequence and resistance to
genetic transformation (Bacon and Hinton 2011). They
have been reported to form surfactin, iturin and fengycin
group of lipopeptide as basis of its antimicrobial effects
(Mounia et al. 2014). Among these compounds, broad
spectrum antibacterial activity have been described for
surfactin and antifungal activity for fengycin.
Bacillus mojavensis associated endophytically with
medicinal plants can expect to have promising lipopeptide
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synthesizing property. Hence, B. mojavensis isolated from
the plant Bacopa monnieri (L.) was selected as organism
for the current study. The plant is used in traditional
medicinal formulations and is having different types of
bacopasides, stigmasterol and other saponins as its active
constituents. The endophytic B. mojavensis isolated from
the plant was observed to have broad antibacterial activity
towards gram positive and gram negative organisms but
was without any antifungal activity. Interestingly, the
organism was positive for surfactin biosynthetic gene in
Fig. 1 Screening of the antibacterial activity of the endophytic
bacteria isolated from Bacopa monnieri using cross streak method.
a Isolate BmB 2, b isolate BmB 3, c isolate BmB 4, d isolate BmB 5,
e isolate BmB 6, f isolate BmB 7, g isolate BmB 11, h control; 1,
Bacillus subtilis; 2, Klebsiella pneumoniae; 3, Staphylococcus aureus;
4, Salmonella enterica Typhi; 5, Escherichia coli
 Isolate BmB 4
 Bacillus mojavensis strain B29 (KF963114)
 Bacillus mojavensis strain CHMS1B4 (KJ787120)
 Bacillus mojavensis strain XA1-8 (JF496257)
 Bacillus licheniformis strain IN10 (JN180125)
 Bacillus firmus strain BSCS3 (HQ397586)
 Bacillus flexus strain EP23 (GQ279347)
 Paenibacillus dendritiformis strain NB12 (JN215506)
 Paenibacillus popilliae strain BPHD (EF190495)
 Pseudomonas aeruginosa strain N146 (JQ900522)
 Klebsiella pneumoniae strain 26 (HQ259959)
 Enterobacter cloacae strain STY35 (HQ220157)
 Enterobacter ludwigii strain M16_2B (JN644496)
 Pantoea agglomerans strain Fbad3 (JN162392)
 Stenotrophomonas rhizophila strain IHB B 985 (GU186108)
 Pseudomonas hibiscicola strain cp17 (JN082269)
 Stenotrophomonas maltophilia isolate 13 (FN645734)
 Pseudomonas geniculata strain CH-X (HQ696469)
 Bordetella avium strain AU9795 (EU082156)
















Fig. 2 The phylogenetic analysis of 16S rDNA sequence of the endophytic bacterial isolate BmB 4 from Bacopa monnieri along with sequences
from NCBI using MEGA 6 with neighbor joining method using 1000 bootstrap replicates
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PCR analysis. Further LC–MS/MS based analysis con-
firmed it to have the ability to synthesize surfactin
(M?H?—1008.6602, 1022.6755) and fengycin (M?H?—
1491.8195, 1477.8055) derivatives. This makes the study
significantly interesting to explore the application of B.
mojavensis in various fields.
Materials and methods
Isolation and identification of endophytic bacteria
with antibacterial activity
Endophytic bacteria isolated from stem of B. monnieri
were checked for its antibacterial activity against Escher-
ichia coli, Salmonella enterica Typhi, Bacillus subtilis,
Klebsiella pneumoniae and Staphylococcus aureus using
perpendicular streak method. For this, the isolates obtained
were initially grown for 5 days at the centre of nutrient
agar plate as single line streak. After incubation, the
pathogens selected were inoculated perpendicular to the
isolate and incubated at 37 C for overnight and observed
for any inhibition.
The bacterial isolate BmB 4 which showed broad
antimicrobial activity was further subjected to molecular
identification. Bacterial genomic DNA from the selected
isolate was purified using Chromous Biotech Bacterial
Genomic DNA Mini Spin Kit (RKT 17) and was further
subjected to PCR amplification of 16S rDNA (Jasim et al.
2013b). The sequence data of 16S rDNA was then used for
BLAST and phylogenetic analysis (Zhang et al. 2000).
Screening for natural product biosynthetic gene
clusters by PCR method
Bacillus mojavensis BmB 4 was screened for natural pro-
duct biosynthetic gene cluster by PCR based method. For
surfactin biosynthetic gene clusters the primer P17 F (50-
ATg AAg ATT TAC ggA ATT TA-30) and P18 R (50-TTA
TAA AAg CTC TTC gTA Cg-30) were used as per the
methods described previously (Tabbene et al. 2011). The
amplified PCR product was checked by agarose gel elec-
trophoresis, sequenced and was further subjected to
BLAST analysis.
Preparation of culture extract and identification
of compounds by LC–MS/MS
For this, B. mojavensis was cultured in 3 L nutrient broth
for 10 days at 30 C in an orbital shaking incubator. The
culture supernatant was extracted twice using double the
volume of ethyl acetate and dried in a rotary vacuum
evaporator at 43 C (Jasim et al. 2014). The dried powder
reconstituted in methanol was used to confirm antibacterial
activity against E. coli, S. Typhi, B. subtilis, K. pneumoniae
and S. aureus by well diffusion method. Same volume of
pure methanol was used as the control.
The extract was then used for LC–MS analysis followed
by LC–MS/MS analysis as per previous methods using
Acquity H-Class (Waters) UPLC with BEH C18 column
(50 mm 9 2.1 mm 9 1.7 lm) and Xevo G2 (Waters)
Quadruple Time of Flight (Q-TOF) Mass spectrometer
(Kumar et al. 2013).
Table 1 Inhibition zone shown by BmB 4 extract towards pathogens
incubated at 24, 48 and 72 h (zone in mm)
Pathogens selected Hours treated
24 h 48 h 72 h
S. Typhi 31 35 30
K. pneumoniae 21.5 22.5 21
B. subtilis 24 28 26
E. coli 21 26 25
S. aureus 36 39.5 30
Fig. 3 PCR screening of surfactin biosynthetic potential of endo-
phytic bacterial isolate BmB 4 from Bacopa monnieri
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Results and discussion
Endophytic microorganisms have been described to have
diverse chemical means to support plant to manage both
biotic and abiotic stress. Presence of bio-interactive natural
products in endophytes and its diversity make it to have
immense applications in agricultural, industrial and medical
fields. Current study selected B. monnieri as the source for
isolation of endophytic bacteria due to its diverse medicinal
applications. The plant has remarkable ability to produce
biomass with in short time in addition to its medici-
nal properties. This also makes it reasonable to expect the
endophytic microbiome of B. monnieri to have candidates
with impressive biosynthetic potential. So the endophytic B.
mojavensis obtained from B. monnieri was studied in detail
to unravel the chemical basis of its antibacterial activity.
 4'-phosphopantetheinyl transferase [Salinibacillus aidingensis] (WP_044161905)
 4'-phosphopantetheinyl transferase [Bacillus axarquiensis] (AFN71164)
 4'-phosphopantetheinyl transferase [Bacillus mojavensis] (AFN71162)
 4'-phosphopantetheinyl transferase [Bacillus mojavensis] (WP_024120191)
 Isolate BmB 4 Srf gene
 4'-phosphopantetheinyl transferase [Bacillus mojavensis] (WP_010332998)
 surfactin biosynthesis protein [Bacillus subtilis] (AIY62580)
 surfactin synthase-activating enzyme [Bacillus subtilis] (AEQ29013)
 surfactin biosynthesis protein [Bacillus subtilis] (AIY62582)








Fig. 4 The phylogenetic analysis of surfactin (srf) gene sequence of the endophytic bacterial isolates BmB 4 along with sequences from NCBI
using MEGA 5 with neighbor joining method using 1000 bootstrap replicates
Fig. 5 Confirmation of antibacterial property using the crude methanolic extract of the selected endophytic bacterial isolate BmB 4 from Bacopa
monnieri. a Bacillus subtilis; b Escherichia coli; c Staphylococcus aureus; d Klebsiella pneumoniae; e Salmonella enterica Typhi
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Isolation and identification of endophytic bacteria
After purifying the endophytic bacteria from the plant tis-
sue, the isolates were screened for antimicrobial properties.
Interestingly the bacterial isolate designated as BmB 4 was
found to have inhibitory effect on all the tested bacterial
pathogens. This included both gram positive and gram
negative organisms like E. coli, S. Typhi, B. subtilis, K.
pneumoniae and S. aureus (Fig. 1). Hence, BmB 4 was
selected for molecular identification.
Fig. 6 LC–MS analysis of the extract of endophytic isolate BmB 4. a LC chromatogram; b MS spectra of m/z 1008.6580; c MS spectra of m/z
1022.6752; d MS spectra of m/z 1489.8971; e MS spectra of m/z 1505.9019
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Fig. 7 LC-MS/MS based fragmentation analysis surfactin (m/z
1008.66 and 1022.68) of extract of isolate BmB 4. a Mass spectra
of m/z 1008.66 showing specific fragments m/z 990, 877, 685, 554 and
441. b Mass spectra of m/z 1022.68 showing specific fragments m/z
1004, 909, 685, 554 and 441
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The PCR amplification product of 16S rDNA of BmB
4 has resulted in a single predominant band at 1500 bp.
Further sequence analysis by BLAST showed the 16S
rDNA of BmB 4 to have 99 % identity to Bacillus
mojavensis. Its distinct clustering to same was also
observed in phylogenetic analysis (Fig. 2). B. mojavensis
isolates with significant bioactivity have already been
reported from different sources including soil from des-
sert. Studies of Bacon et al. (2006) have previously
reported the endophytic nature of B. mojavensis in maize
with significant activity against Fusarium sp. Other than
this, only limited reports are there on the endophytic
distribution of B. mojavensis. This suggests the signifi-
cance of exploration of this species from medicinally
important plants. Remarkably the B. mojavensis BmB 4
was identified to be highly specialized for broad spectrum
antibacterial activity. It was different from previous
Bacillus spp. reported from our previous study due to the
lack of antifungal activity. Also the values observed for
the zone of inhibition caused by B. mojavensis in the
study against the tested clinical pathogens were signifi-
cantly high (Table 1).
Screening for natural product biosynthetic gene
clusters by PCR method
For the rapid screening of genetic basis of antibacterial
activity of BmB 4, it was subjected to PCR using primers
specific to various natural product biosynthetic gene clus-
ters. Interestingly, BmB 4 was found to be positive for
surfactin (srf) biosynthesis gene due to the formation of a
product with the expected size of 645 bp (Fig. 3). Upon
BLAST analysis of sequence data, it showed 100 % iden-
tity towards 40-phosphopantetheinyl transferase of B.
mojavensis (WP_010332998) and the same was reflected in
the phylogenetic analysis also (Fig. 4). Thus, B. mojavensis
BmB 4 was confirmed to have the genomic basis for sur-
factin biosynthesis. Its presence in the medicinal plant B.
monnieri as an endophyte adds its significance as it is very
reasonable to consider its biosynthetic potential to be
favorable for the plant.
Confirmation of antibacterial activity
For this, the crude extract from BmB 4 was checked for
activity against E. coli, S. Typhi, B. subtilis, K. pneumoniae
and S. aureus. The extract from BmB 4 was found to have
high inhibition towards most of the pathogens tested
(Fig. 5). This is of particular interest as the test organisms
selected included both gram positive and gram negative
organisms. So B. mojavensis isolated in the study can be
confirmed to have the chemical means to act against broad
range of bacterial pathogens. Upon time-dependent analy-
sis of activity of extract of BmB 4, the activity against test
pathogens was found to be high at 48 h incubation, com-
pared to that at 24 and 72 h (Table 1). This also make it to
be an impressive candidate organism for natural product
study. Based on PCR results of the study, presence of
surfactin as one of the promising chemicals was also
expected. To further confirm this, the extract from BmB 4
was subjected to detailed LC–MS analysis.
LC–MS analysis of extract from B. mojavensis BmB
4
Before the LC–MS analysis, the crude methanolic extract
prepared from B. mojavensis was checked for its activity
against the selected pathogens by well diffusion method.
This confirmed the presence of antimicrobial compounds in
the prepared extract. LC–MS analysis of the extract
showed the presence of surfactin and fengycin derivatives
with m/z of 1008.6580 and 1022.6752 (M?H?) and m/z
1489.8971 and 1505.9019 (M?H?), respectively, in the
extract. Presence of same mass in positive and negative
mode ionization was considered as confirmation of pres-
ence of surfactin and fengycin in the extract (Fig. 6).
In the case of surfactin (1008.6 and 1022.6), the detailed
LC–MS/MS analysis of m/z 1008.6 showed the presence of
fragmented masses 990, 877.5592, 685.4487, 554.3859,
441.2712 and it confirmed the compound as surfactin. For
m/z of 1022.6 the fragmentation analysis masses 1004,
909.5881, 891, 685.4504, 554.3569, 441.2724 was confir-
matory to its identity as surfactin (Fig. 7; Table 2).
Table 2 Summary of the masses identified along with the fragmented masses by LC–MS/MS analysis
No. Compounds identified Retention time Molecular ions (m/z) Fragmented mass (m/z)
[M?H?] [M-H-]
1. Surfactin derivatives 7.998 1008.6580 1006.6470 990, 877.5592,685.4487, 554.3859, 441.2712
8.061 1022.6752 1020.6615 1004, 909.5881,891, 685.4504, 554.3569, 441.2724
2. Fengycin derivatives 6.058 1489.8971 1487.3312 1108, 994
6.851 1505.9019 1503.8871 1108.5684, 966 675.4319
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Fig. 8 LC-MS/MS based fragmentation analysis fengycin (m/z 1489.90 and 1505.89) of extract of isolate BmB 4. a Mass spectra of m/z 1489.90
showing specific fragments m/z 1108 and 966. b Mass spectra of m/z 1505.89 showing specific fragments m/z 1108, 966 and 675
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Interestingly, the presence of key mass 685 was found to be
conserved in both cases (Tang et al. 2010).
Fengycin was also identified due to the presence of
masses 1491.8195 and 1505.9019 in the initial MS analy-
sis. The fragmentation of 1489.8971 (M?H?) gave masses
1080, 966 and 675 specific to fengycin B (Fig. 8; Table 2).
Likewise, fragmentation of m/z 1505.9019 proved the
presence of masses 1108 and 994 to confirm it as fengycin.
The detailed mass fragmentation analysis confirmed the
chemical basis of broad antimicrobial activity of BmB 4 as
due to surfactin and fengycin.
Several strains of B. subtilis have been reported to
produce a range of antimicrobial cyclic lipopeptides
including fengycins and surfactins with broad antimicro-
bial properties (Arrebola et al. 2010). B. mojavensis iso-
lated from diverse environments have been reported to
have significant activity against phytopathogens also
(O¨zyilmaz and Benlioglu 2013). But B. mojavensis BmB 4
isolated in the study was not found to have any activity
against phytopathogens when it was tested and it might
have specialised for broad antibacterial activity as part of
its endophytic adaptation. Fengycin group of compounds
produced by B. mojavensis have been reported to have high
antimicrobial activity (Mounia et al. 2014). However, its
endophytic origin makes the current result highly impres-
sive. Fengycins are synthesized nonribosomally by peptide
synthetases encoded by fenC, fenD, fenE, fenA and fenB
genes. Each of the peptide synthetase contains an adeny-
lation domain which recognizes and specifically adenylates
aminoacids to form thioester bond with the cofactor
40phosphopantetheine at the thiolation domain. The
transpeptidation process extends the peptide length by
transferring the activated amino acids in the initiation
module to the activated amino acid in the thiolation domain
in the next module. This process continues in a linear
manner from one module to another till the entire molecule
is constructed (Steller et al. 1999; Lin et al. 1999; Shu et al.
2002; Wu et al. 2007).
Bacillus sp. have already been reported to produce
mixtures of closely related cyclic lipopeptide isoforms of
the biosurfactant surfactin A (Snook et al. 2009). Among
the many anticipated uses of surfactin, it is considered to be
inhibitory to fungi, bacteria, mycoplasmas, and viruses
(Bacon et al. 2012). The most remarkable feature high-
lighted with the surfactin is its broad range antibacterial
activity. So the antibacterial basis of BmB 4 shown in the
study can either be due to the activity of surfactin alone or
its synergistic effect with fengycin. The lipopeptides
extracted from B. subtilis UMAF6639 have been described
to have iturin A, fengycin and surfactin as its chemical
basis to inhibit spore germination (Marrone 2002). As
lipopeptides are known to disrupt the microbial cytoplas-
mic membrane by creating transmembrane channels
leading to the release of vital ions such as K? (Hsieh et al.
2008), the result obtained in the study is very significant.
Conclusion
From this study, endophytic B. mojavensis obtained from
B. monnieri was confirmed for its potential to produce
different classes of lipopeptides with broad spectrum
antibacterial activity. As the antimicrobial potential of
endophytic Bacillus species from medicinal plants are least
investigated, the result of this study is significantly
important and can have promising applications as the
potential of lipopeptides is just began to explore.
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